Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, Novavax, Inc’s stock clocked out at $8.10, up 2.27% from its previous closing price of $7.92. In other words, the price has increased by $2.27 from its previous closing price. On the day, 2.84 million shares were traded. NVAX stock price reached its highest trading level at $8.185 during the session, while it also had its lowest trading level at $7.86.
Ratios:
To gain a deeper understanding of NVAX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.97 and its Current Ratio is at 0.98.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on February 28, 2025, initiated with a Buy rating and assigned the stock a target price of $19.
On July 30, 2024, JP Morgan Downgraded its rating to Underweight which previously was Neutral but kept the price unchanged to $8.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 13 ’24 when King Rachel K. sold 4,150 shares for $9.02 per share. The transaction valued at 37,435 led to the insider holds 14,770 shares of the business.
YOUNG JAMES F sold 5,400 shares of NVAX for $43,200 on Dec 31 ’24. The Director now owns 51,760 shares after completing the transaction at $8.00 per share. On Dec 24 ’24, another insider, YOUNG JAMES F, who serves as the Director of the company, sold 4,600 shares for $8.48 each. As a result, the insider received 39,008 and left with 57,160 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVAX now has a Market Capitalization of 1302836480 and an Enterprise Value of 614239040. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.91. Its current Enterprise Value per Revenue stands at 0.9 whereas that against EBITDA is -3.349.
Stock Price History:
The Beta on a monthly basis for NVAX is 3.03, which has changed by 0.626506 over the last 52 weeks, in comparison to a change of 0.087141395 over the same period for the S&P500. Over the past 52 weeks, NVAX has reached a high of $23.86, while it has fallen to a 52-week low of $3.81. The 50-Day Moving Average of the stock is -3.84%, while the 200-Day Moving Average is calculated to be -27.26%.
Shares Statistics:
It appears that NVAX traded 4.31M shares on average per day over the past three months and 5144440 shares per day over the past ten days. A total of 160.42M shares are outstanding, with a floating share count of 146.60M. Insiders hold about 8.86% of the company’s shares, while institutions hold 59.80% stake in the company. Shares short for NVAX as of 1740700800 were 39225752 with a Short Ratio of 9.10, compared to 1738281600 on 34935605. Therefore, it implies a Short% of Shares Outstanding of 39225752 and a Short% of Float of 30.380000000000003.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
